Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice

Genes and Development

Volumn 9, Issue 16, 1995, Pages 2020-2033

  Suh, Theodore T ^a   Holmbäck, Kenn ^a   Jensen, Nancy J ^a   Daugherty, Cynthia C ^a   Small, Kersten ^a,b   Simon, Daniel I ^c   Potter, S Steven ^a   Degen, Jay L ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b EMORY UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

afibrinogenemia; coagulation; development; Fibrinogen deficient mice; hemostasis; platelet aggregation; wound healing

Indexed keywords

FIBRINOGEN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FETUS OUTCOME; FIBRINOGEN DEFECT; HEMOSTASIS; HISTOPATHOLOGY; MALE; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; TRANSGENIC MOUSE; WOUND HEALING;

ANIMALIA; MUS MUSCULUS;

EID: 0029147959     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.9.16.2020     Document Type: Article

References (65)

1. Al-Mondhiry, H. and W.C. Ehmann. 1994. Congenital afibrinogenemia. Am. J. Hematol. 46: 343-347.
2. Altieri, D.C., P.M. Mannucci, and A.M. Capitanio. 1986. Binding of fibrinogen to human monocytes. J. Clin. Invest. 78: 968-976.
3. 2, Mac-1) and promotes leukocyte adhesion. J. Biol. Chem. 268: 1847-1853.
4. Baehner, R.L., and H.S. Strauss. 1966. Hemophilia in the first year of life. N. Engl. J. Med. 275: 524-528.
5. Bell, S.M., R.W. Brackenbury, N.D. Leslie, and J.L. Degen. 1990. Plasminogen activator gene expression is induced by the src oncogene product and tumor promoters. J. Biol. Chem. 265: 1333-1338.
6. Bennett, J.S. 1991. Integrin structure and function in hemostasis and thrombosis. Ann. N.Y. Acad. Sci. 614: 214-228.
7. Bini, A. and B. Kudryk. 1992. Fibrin and its derivatives in the normal and diseased vessel wall. Ann. N.Y. Acad. Sci. 667: 112-126.
8. Brown, L.F., N. Lamr, J. McDonagh, K. Tognazzi, A.M. Dvorak, and H.F. Dvorak. 1993. Fibroblast migration in fibrin gel matrices. Am. J. Pathol. 142: 273-283.
9. Bugge, T.H., M.J. Flick, C.C. Daugherty, and J.L. Degen. 1995. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes & Dev. 9: 794-807.
10. Chung, D.W. and A. Ichinose. 1995. Hereditary disorders of fibrinogen and factor XIII. In The metabolic and molecular bases of inherited disease, 7th ed. (ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle), pp. 3223-3240. McGraw-Hill, New York.
11. Chung, D.W., J.E. Harris, and E.W. Davie. 1990. Nucleotide sequence of the three genes coding for human fibrinogen. In Fibrinogen, thrombosis, coagulation, and fibrinolysis (ed. C.Y. Liu and S. Chien], pp. 39-48. Plenum Press, New York.
12. Collen, D. and H.R. Lijnen. 1994. Fibrinolysis and the control of hemostasis. In The molecular basis of blood diseases, 2nd ed. (ed. G.S. Stamatoyannopoulos, A.W. Nienhuis, P.W. Majerus, and H. Varmus), pp. 725-752. W.B. Saunders Co., Philadelphia, PA.
13. Colvin, R.B., R.A. Johnson, M.C. Mihm Jr., and H.F. Dvorak. 1973. Role of the clotting system in cell-mediated hypersensitivity. Fibrin deposition in delayed skin reactions in man. J. Exp. Med. 138: 686-698.
14. Costantini, V. and L.R. Zacharski. 1992. The role of fibrin in tumor cell metastasis. Cancer Metastasis Rev. 11: 283-290.
15. Crabtree, G.R. and J.A. Kant. 1982. Coordinate accumulation of the mRNA for the α, β, and γ chains of rat fibrinogen following defibrination. J. Biol. Chem. 257: 7277-7279.
16. Crabtree, G.R., C.M. Comeau, D.M. Fowlkes, A.J. Fornace Jr., J.D. Malley, and J.A. Kant. 1985. Evolution and structure of the fibrinogen genes. Random insertion of introns or selective loss? J. Mol. Biol. 185: 1-19.
17. Cross, J.C., Werb, Z., and S.J. Fisher. 1994. Implantation and the placenta: Key pieces of the developmental puzzle. Science 266: 1508-1518.
18. Dahlbäck, B. and J. Stenflo. 1994. The protein C anticoagulant system. In The molecular basis of blood diseases, 2nd ed. (ed. G.S. Stamatoyannopoulos, A.W. Nienhuis, P.W. Majerus, and H. Varmus), pp. 599-627. W.B. Saunders Co., Philadelphia, PA.
19. Davie E.W., K. Fujikawa, and W. Kisiel. 1991. The coagulation cascade: Initiation, maintenance, and regulation. Biochemisty 30: 10363-10370.
20. Degen, J.L., R.D. Estensen, Y. Nagamine, and E. Reich. 1985. Induction and desensitization of plasminogen activator gene expression by tumor promoters. J. Biol. Chem. 260: 12426-12433.
21. Degen, S.J.F., S.M. Bell, L.A. Schaefer, and R.W. Elliott. 1990. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17. Genomics 8: 49-61.
22. Dejana, E., L.R. Languino, N. Polentarutti, G. Balconi, J.J. Ryckewaert, M.J. Larrieu, M.B. Donati, A. Mantovani, and G. Marguerie. 1985. Interaction between fibrinogen and cultured endothelial cells: Induction of migration and specific binding. J. Clin. Invest. 75: 11-18.
23. DeMarco, L., A. Girolami, T.S. Zimmerman, and Z.M. Ruggeri. 1986. von Willebrand factor interaction with the glycoprotein IIb/IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J. Clin. Invest. 77: 1272-1277.
24. Donaldson, D.J., J.T. Mahan, D.L. Amrani, D.H. Farrell, and J.H. Sobel. 1994. Further studies on the interaction of migrating keratinocytes with fibrinogen. Cell Adhes. Commun. 2: 299-308.
25. Doolittle, R.F. 1994. The molecular biology of fibrin. In The molecular basis of blood diseases (ed. G.S. Stamatoyannopoulos, A.W. Nienhuis, P.W. Majerus, and H. Varmus], pp. 701-723. W.B. Saunders Co., Philadelphia, PA.
26. Dvorak, H.F. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315: 1650-1659.
27. Dvorak, H.F., J.A. Nagy, B. Berse, L.F. Brown, K.-T. Yeo, T.-K. Yeo, A.M. Dvorak, L. Van De Water, T.M. Siousat, and D.R. Senger. 1992. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann. N.Y. Acad. Sci. 667: 101-111.
28. Ehmann, W.C. and H. Al-Mondhiry. 1994. Congenital afibrinogenemia and splenic rupture. Am. J. Med. 96: 92-94.
29. Esmon, C.T. 1993. Cell mediated events that control blood coagulation and vascular injury. Annu. Rev. Cell Biol. 9: 1-26.
30. Feinberg, A.P. and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6-13.
31. Francis, R.B. and R.P. Hebbel. 1994. Hemostasis. In Sickle cell disease: Basic principles and clinical practice (ed. S.H. Embury, R.P. Hebbel, N. Mohandas, and M.H. Steinberg), pp. 299-310. Raven Press, New York.
32. Guy, C.T., R.D. Cardiff, and W.J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic model for metastatic disease. Mol. Cell. Biol. 12:954-961.
33. Heckel, J.L., E.P. Sandgren , J.L. Degen, R.D. Palmiter, and R.L. Brinster. 1990. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 62: 447-456.
34. Hooper, M.L., K. Hardy, A. Handyside, S. Hunter, and M. Monk. 1987. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326: 292-295.
35. Huang, S., E.R. Mulvihill, D.H. Farrell, C.W. Chung, and E.W. Davie. 1993. Biosynthesis of human fibrinogen. Subunit interactions and potential intermediates in assembly. J. Biol. Chem. 268: 8919-8926.
36. 3 integral in mediating fibrin gel retraction. J. Biol. Chem. 270: 1785-1790.
37. Languino, L.R., A. Duperray, K.J. Joganic, M. Fornaro, G.B. Thornton, and D.C. Altieri. 1995. Regulation of leukocyte-endothelial interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc. Natl. Acad. Sci. 92: 1505-1509.
38. Li, H., D.P. Witte, W.W. Branford, B.J. Aronow, M. Weinstein, S. Kaur, S. Wert, G. Singh, C.M. Schreiner, J.A. Whitsett, W.J. Scott, and S.S. Potter 1994. Gsh-4 encodes a LIM-type homeodomain, is in the developing nervous system and is required for early postnatal survival. EMBO J. 13: 2876-2885.
39. Majerus, P.W. 1994. Platelets. In The molecular basis of blood diseases (ed. G.S. Stamatoyannopoulos, A.W. Nienhuis, P.W. Majerus, and H. Varmus), pp. 753-785. W.B. Saunders Co., Philadelphia, PA.
40. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes. Nature 336: 348-352.
41. Marder, V.J., D.I. Feinstein, C.W. Francis, and R.W. Colman. 1994. Consumptive thrombohemorrhagic disorders. In Hemostasis and thrombosis, basic principles and clinical practices (ed. R.W. Colman, J. Hirsh. V.J. Marder, and E.W. Salzman], pp. 1023-1063. J.B. Lipponcott, Philadelphia, PA.
42. McRitchie, D.I., M.J. Girotti, M.F.X. Glynn, J.M. Goldberg, and O.D. Rotstein. 1991. Effect of systemic fibrinogen depletion on intraabdominal abscess formation. J. Lab. Clin. Med. 118:48-55.
43. Montgomery, R.R. and J.P. Scott. 1993. Hemostasis: Diseases of the fluid phase. In Hematology of infancy and childhood (ed. D.G. Nathan and F.A. Oski), pp. 1605-1650. W.B. Saunders Co., Philadelphia, PA.
44. Nagy, J.A., E.S. Morgan, K.T. Herzberg, E.J. Manseau, A.M. Dvorak, and H.F. Dvorak. 1995. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res. 55: 376-385.
45. Naito, M., C. Funaki, T. Hayashi, K. Yamada, K. Asai, N. Yoshimine, and F. Kuzuya. 1992. Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cells. Atherosclerosis 96: 227-234.
46. Oski, F.A. 1982. Blood coagulation disorders in the newborn. In Hematologic problems in the newborn (ed. F.A. Oski and J.L. Naiman), pp. 137-174. W.B. Saunders Co., Philadelphia, PA.
47. Plow, E.F. and T.S. Edgington. 1986. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the Aα chain. J. Immunol. 137: 1910-1915.
48. Plow, E.F., A.H. Srouji, D. Meyer, G.A. Marguerie, and M.H. Ginsberg. 1984. Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J. Biol. Chem. 259: 5385-5391.
49. Plump, A.S., J.D. Smith, T. Hayek, K. Aatlto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin, and J.L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
50. Reid, L.H., R.G. Gregg, O. Smithies, B.H. Koller. 1990. Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc. Natl. Acad. Sci. 87: 4299-4303.
51. Roy, S.N., R. Procyk, B.J. Kudryk, and C.M. Redman. 1991. Assembly and secretion of recombinant human fibrinogen. J. Biol. Chem. 266: 4758-4763.
52. Ruggeri, Z.M., L. DeMarco, L. Gatti, R. Bader, R.R. Montgomery. 1983. Platelets have more than one binding site for von Willebrand factor. J. Clin. Invest. 72: 1-12.
53. Sadler, J.E. and E.W. Davie. 1994. Hemophilia A, hemophilia B, and von Willebrand disease. In The molecular basis of blood diseases (ed. G.S. Stamatoyannopoulos, A.W. Nienhuis, P.W. Majerus, and H. Varmus), pp. 657-700. W.B. Saunders Co., Philadelphia, PA.
54. Sherman, L.A. and J. Lee. 1977. Specific binding of soluble fibrin to macrophages. J. Exp. Med. 145: 76-85.
55. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
56. Sierra, D.H. 1993. Fibrin sealant adhesive systems: A review of their chemistry, material properties and clinical applications. J. Biomater. Appl. 7: 309-352.
57. Simon, D.I., A.M. Ezratty, S.A. Francis, H. Rennke, and J. Loscalzo. 1993. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b-CD18): A nonplasmin fibrinolytic pathway. Blood 82: 2414-2422.
58. Skogen, W.F., R.M. Senoir, G.L. Griffin, and G.D. Wilner. 1988. Fibrinogen-derived peptide Bb1-42 is a multidomained neutrophil chemoattractant. Blood 71: 1475-1479.
59. Tang, L. and J.W. Eaton. 1993. Fibrin(ogen) mediates acute inflammation reponses to biomaterials. J. Exp. Med. 178: 2147-2156.
60. Thiagarajan, P. and K.L. Kelly. 1988. Exposure of binding sites for vitronectin on platelets following stimulation. J. Biol. Chem. 263: 3035-3038.
61. Trudel, M., M.E. DePaepe, N. Chrétien, N. Saadane, J. Jacmain, M. Sorette, T. Hoang, and Y. Beuzard. 1994. Sickle cell disease in transgenic SAD mice. Blood 84: 3189-3197.
62. Wehinger, H., O. Klinge, E. Alexandrakis, J. Schurmann, J. Witt, and H.H. Seydewitz. 1983. Hereditary hypofibrinogenemia with fibrinogen storage in the liver. Eur. J. Pediatr. 141: 109-112.
63. Weiss, H.J., J. Hawiger, Z.M. Ruggeri, V.T. Turitto, P. Thiagarajan, and T. Hoffmann. 1989. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J. Clin. Invest. 83: 288-297.
64. Wright, S.D., J.S. Weitz, A.J. Huang, S.M. Levin, S.C. Silverstein, and J.D. Leike. 1983. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. 85: 7734-7738.
65. Zhang, S.H., R.L. Reddick, J.A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.